Navigation Links
Bio-Optronics Incorporates RxPaying(TM) Patient Stipend Debit Card Feature in Clinical Conductor(TM) Clinical Trial Management System (CTMS)
Date:4/21/2009

ROCHESTER, N.Y., April 21 /PRNewswire/ -- Bio-Optronics, Inc. will enhance its Clinical Conductor(TM) Clinical Trial Management System with click-through integration to Interspond's RxPaying(TM) debit card solution. This offers a patient stipend payment alternative which improves efficiency and increases patient satisfaction. Clinical Conductor(TM) CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly. Dan Kerpelman, President and CEO states, "We are pleased to be integrating RxPaying(TM) debit cards as an efficient alternative to the patient stipend payment process and will continue to leverage Clinical Conductor(TM) as the entry point for seamless integration to tools that optimize efficiency, productivity, and improve collaboration across the clinical environment."

Clinical Conductor(TM) CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting, and provides an innovative Electronic Data Capture option. The academic medical center clinical trial management system solution adds research administration capabilities and custom interfaces to hospital enterprise systems.

The Rx Paying(TM) Debit Card helps ensure higher patient participation and retention by providing immediate access to their funds, which can be used to purchase items, request cash back from a purchase or get cash from an ATM. It centralizes the process of patient reimbursement for clinical studies as a whole. "Integrating RxPaying(TM) with Clinical Conductor(TM), one of the leading CTMS in the industry, is a natural fit and we are excited about our partnership. While both products are excellent stand-alone systems, the integration creates a more dynamic product by eliminating redundancy and streamlining the reimbursement process," according to Kathy S. Cox, President & CEO of Interspond.

Bio-Optronics, Inc. develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction. For over 20 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service. Our workflow solutions are used in over 30 Veterans' Administration and other hospitals in the U.S., and over 400 clinical research sites around the world. www.bio-optronics.com

Interspond is a Trial Management Organization (TMO) for the pharmaceutical and biotechnology industries working to identify study opportunities for sites' participation. We maintain a database of hundreds of qualified, experienced investigative sites capable of conducting Phase I through Phase IV studies. These sites are located throughout the country and are multi-therapeutic in nature. Our RxPaying(TM) service offers electronic reimbursement for the clinical research industry. RxPaying(TM) streamlines and simplifies the process of reimbursing patients for participation in clinical research studies through the use of an instant issue debit card. www.interspond.com

CONTACT: Bio-Optronics, (877) 279-8377, www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife
2. ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome
3. First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
4. Surveyed Specialists Foresee Greater Use of Parenteral Outpatient Therapy for the Treatment of Osteomyelitis
5. WakeMed Shares Best Practices for Tracking Assets, Patients
6. Tragic choices: Is it better for doctors or patient families to decide?
7. Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost
8. Genetic variants predict recurrence of bladder cancer, patient survival
9. Acupuncture eases radiation-induced dry mouth in cancer patients
10. Doctor-Patient Talks Key to Blacks Getting Cancer Screens
11. PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Diagnotes, ... as a standard feature on its secure clinical communication platform. The platform allows ... video depending on the type and urgency of a situation. , “We ...
(Date:5/23/2017)... ... 23, 2017 , ... New patients with symptoms of gum disease ... laser gum disease treatments from the doctors at Art of Dentistry, without first receiving ... of the importance of receiving qualified treatment in order to avoid systemic health effects ...
(Date:5/23/2017)... Horeb, WI (PRWEB) , ... May 23, 2017 , ... ... invited to call Dr. Angela Cotey’s practice to schedule an appointment, with or without ... services, and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative to ...
(Date:5/22/2017)... ... May 22, 2017 , ... Dr. Kiya Green, ... with periodontal plastic surgery treatments, including crown lengthening and gum reduction ... these esthetic and functional procedures to help patients improve their oral health, reduce ...
(Date:5/22/2017)... , ... May 22, 2017 , ... “Homeostasis: The Journey ... learning to live with Bipolar 1. Donald Rodriguez takes readers on a rollercoaster ride ... in the dead of winter and to a dark place where Donald considers suicide. ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... -- The Corporate Whistleblower Center says, "We are urging ... to call us anytime at 866-714-6466 if they possess ... a substantial scheme to overbill Medicare. We are ... of a medical equipment company if their employer ... practice groups with extra generous incentives to use, or ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
Breaking Medicine Technology: